ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 2

Subgrouping Patients with Advanced NSCLC for Tailored Treatment

, ,

The panel discusses how patients with advanced NSCLC are sub-grouped in NSCLC and how to approach treatment for each group.

Sponsored in part by Regeneron. Content independently created by OncLive.